NCT06898905
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Yale University New Haven, Connecticut, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
Recruiting
Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?
NCT06352242
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Clinical hematology department, University Hospital Montpellier, France
- Clinical Investigation Center, University Hospital Montpellier, France
NCT06977711
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University Hospital System San Antonio, Texas, United States
- University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center San Antonio, Texas, United States
NCT05700149
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- Weill Cornell Medical New York, United States
- Ohio Health Riverside Methodist Hospital Columbus, Ohio, United States
NCT06971848
- Conditions
- AL Amyloidosis, Adenocarcinoma, Adenoma, +75 more
- Locations
-
- CHU Angers Angers, France
NCT07502768
- Conditions
- Disease Attributes, Extranodal NK/T-cell Lymphoma, Lymphoma, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission
NCT07507318
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT07231952
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center (Data Collection Only) Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925
- Conditions
- Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
- Locations
-
- Dren Investigational Site Birmingham, Alabama, United States
- Dren Investigational Site Duarte, California, United States
- Dren Investigational Site Irvine, California, United States
- Dren Investigational Site Redwood City, California, United States
NCT05463263
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Memorial Sloan Kettering New York, United States
- Hôpital Saint-Louis Paris, France